Biosynthetic pathway of 2-deoxystreptamine.
- 1 January 1981
- journal article
- research article
- Published by Japan Antibiotics Research Association in The Journal of Antibiotics
- Vol. 34 (1) , 13-15
- https://doi.org/10.7164/antibiotics.34.13
Abstract
Four 2-deoxystreptamine (DOS) related compounds including S-11-P, isolated as an intermediate of DOS biosynthesis, were supplemented to the culture of a DOS- mutant of Bacillus circulans. Among the tested aminocyclitol compounds, S-11-P alone was converted to DOS. Addition of other aminocyclitols neither produced antibiotic nor inhibited the incorporation of S-11-P and DOS into butirosins. By these facts, S-11-P was confirmed clearly to be an intermediate of DOS biosynthesis.This publication has 5 references indexed in Scilit:
- Production of a new aminoglycoside antibiotic by a mutant of Bacillus circulans.The Journal of Antibiotics, 1980
- Structure elucidation of an intermediate of 2-deoxystreptamine biosynthesis.The Journal of Antibiotics, 1980
- Isolation of an intermediate of 2-deoxystreptamine biosynthesis from a mutant of Bacillus circulans.The Journal of Antibiotics, 1980
- Mutational biosynthesis by idiotrophs of Micromonospora purpurea. II. Conversion of non-amino containing cyclitols to aminoglycoside antibiotics.The Journal of Antibiotics, 1977
- Antibiotics derived from a mutant of Bacillus circulans.The Journal of Antibiotics, 1976